Sitemap

October 03, 2012 Articles

Filter by Available Specialty
  1. Alimera raises $40 million to market Iluvien
  2. Argentina officially recognizes optometry
  3. Changing indications for bilateral TKA did not decrease complications
  4. Colorectal cancer task force updates colonoscopy surveillance guidelines
  5. ConforMIS releases knee replacement system
  6. C-reactive protein, fibrinogen improved CV event prediction
  7. Dengue virus dissemination in Puerto Rico different from previous serotypes
  8. Department of Justice drops DaVita investigation
  9. Emergency transport directly to a PCI center significantly reduced mortality
  10. FDA approves Sorilux Foam for treatment of scalp plaque psoriasis
  11. Female gender does not affect acute concussive soccer injuries, study finds
  12. HCT survivors at increased risk for heart disease
  13. Health care costs lower with home-based chronic HF management
  14. Injection-free exenatide well tolerated, effective at higher doses
  15. Interleukin-20 expressed in lesions, tissue in patients with psoriasis, PsA
  16. Investigational DPP-IV inhibitor at various doses reduced HbA1c in type 2 diabetes
  17. Little evidence to back medical interventions for autism
  18. Many HBV, HCV infections remain unidentified in US
  19. More data needed to characterize MRSA risk at hospitalization
  20. Patients with early-grade OA experienced post-TKA pain, dissatisfaction
  21. Patients with metastatic melanoma improved progression-free survival with Abraxane
  22. Patients, doctors may benefit from shared access to visit notes
  23. Prolonged analgesic use failed to reduce postmenopausal breast cancer risk
  24. Psychiatric and movement disorders may share genetic link
  25. Shorter therapy effectively treated pediatric patients’ allergies to dust mites
  26. Statins may lower glaucoma risk in people with hyperlipidemia
  27. Statins may lower glaucoma risk in people with hyperlipidemia
  28. Synergetics reports $1.9 million fourth-quarter net income
  29. Vision loss after anti-VEGF treatment linked to AMD progression